Cargando…
Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives
Due to their high specificity, monoclonal antibodies have been widely investigated for their application in drug delivery to the central nervous system (CNS) for the treatment of neurological diseases such as stroke, Alzheimer’s, and Parkinson’s disease. Research in the past few decades has revealed...
Autores principales: | Kouhi, Aida, Pachipulusu, Vyshnavi, Kapenstein, Talya, Hu, Peisheng, Epstein, Alan L., Khawli, Leslie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235515/ https://www.ncbi.nlm.nih.gov/pubmed/34208575 http://dx.doi.org/10.3390/ijms22126442 |
Ejemplares similares
-
Spatio-temporal biodistribution of (89)Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model
por: Sta Maria, Naomi S., et al.
Publicado: (2021) -
Antibody targeted CpG for the immunotherapy of solid tumors
por: Epstein, Alan L, et al.
Publicado: (2015) -
Principles of N-Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations
por: Boune, Souad, et al.
Publicado: (2020) -
Invited Perspective: Challenging the Dogma of Lead Neurotoxicity
por: Guilarte, Tomás R.
Publicado: (2023) -
Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma
por: Zheng, Long, et al.
Publicado: (2017)